{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:57:25Z","timestamp":1790693845716,"version":"4.1.0"},"reference-count":50,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.3201\/eid2602.181120","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T14:41:39Z","timestamp":1576161699000},"page":"229-237","source":"Crossref","is-referenced-by-count":10,"title":["Exposure to Ebola Virus and Risk for Infection with Malaria Parasites, Rural Gabon"],"prefix":"10.3201","volume":"26","author":[{"given":"Jessica L.","family":"Abbate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Becquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa O.","family":"Ezenwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2602.181120-202001160947-R1","doi-asserted-by":"publisher","first-page":"e0005265","DOI":"10.1371\/journal.pntd.0005265","article-title":"Predicting Ebola severity: a clinical prioritization score for Ebola virus disease.","volume":"11","author":"Hartley","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.medmal.2014.09.009","article-title":"Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features.","volume":"44","author":"Barry","year":"2014","journal-title":"Med Mal Infect"},{"key":"key-10.3201\/eid2602.181120-202001160947-R3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1473-3099(17)30112-3","article-title":"Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study.","volume":"17","author":"Waxman","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504605","article-title":"Effect of artesunate-amodiaquine on mortality related to Ebola virus disease.","volume":"374","author":"Gignoux","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2602.181120-202001160947-R5","doi-asserted-by":"publisher","first-page":"e00325","DOI":"10.1128\/mSphereDirect.00325-17","article-title":"Deep sequencing of RNA from blood and oral swab samples reveals the presence of nucleic acid from a number of pathogens in patients with acute Ebola virus disease and is consistent with bacterial translocation across the gut.","volume":"2","author":"Carroll","year":"2017","journal-title":"MSphere"},{"key":"key-10.3201\/eid2602.181120-202001160947-R6","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/cid\/ciw452","article-title":"Plasmodium parasitemia associated with increased survival in Ebola virus-infected patients.","volume":"63","author":"Rosenke","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S1473-3099(15)70124-6","article-title":"Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis.","volume":"15","author":"Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R8","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1126\/science.aaa3438","article-title":"Reduced vaccination and the risk of measles and other childhood infections post-Ebola.","volume":"347","author":"Takahashi","year":"2015","journal-title":"Science"},{"key":"key-10.3201\/eid2602.181120-202001160947-R9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3201\/eid2203.150977","article-title":"Effects of response to 2014\u20132015 Ebola outbreak on deaths from malaria, HIV\/AIDS, and tuberculosis, West Africa.","volume":"22","author":"Parpia","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R10","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(16)00077-3","article-title":"Sequelae of Ebola virus disease: the emergency within the emergency.","volume":"16","author":"Vetter","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R11","unstructured":"World Health Organization. World Malaria Report 2017 [cited 2019 Dec 5) http:\/\/apps.who.int\/iris\/bitstream\/10665\/259492\/1\/9789241565523-eng.pdf"},{"key":"key-10.3201\/eid2602.181120-202001160947-R12","doi-asserted-by":"publisher","first-page":"e1000048","DOI":"10.1371\/journal.pmed.1000048","article-title":"A world malaria map: Plasmodium falciparum endemicity in 2007.","volume":"6","author":"Hay","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2602.181120-202001160947-R13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.micinf.2005.04.006","article-title":"The natural history of Ebola virus in Africa.","volume":"7","author":"Pourrut","year":"2005","journal-title":"Microbes Infect"},{"key":"key-10.3201\/eid2602.181120-202001160947-R14","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMp1807691","article-title":"Outbreaks in a rapidly changing Central Africa\u2014lessons from Ebola.","volume":"379","author":"Munster","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2602.181120-202001160947-R15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1473-3099(19)30118-5","article-title":"Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment.","volume":"19","author":"Mbala-Kingebeni","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R16","doi-asserted-by":"publisher","first-page":"e0007428","DOI":"10.1371\/journal.pntd.0007428","article-title":"Estimating undetected Ebola spillovers.","volume":"13","author":"Glennon","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R17","doi-asserted-by":"publisher","first-page":"e9126","DOI":"10.1371\/journal.pone.0009126","article-title":"High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.","volume":"5","author":"Becquart","year":"2010","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2602.181120-202001160947-R18","doi-asserted-by":"publisher","first-page":"S768","DOI":"10.1093\/infdis\/jir344","article-title":"Risk factors for Zaire ebolavirus\u2014specific IgG in rural Gabonese populations.","volume":"204","author":"Nkoghe","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R19","doi-asserted-by":"publisher","first-page":"e0126933","DOI":"10.1371\/journal.pone.0126933","article-title":"No evidence for ape Plasmodium infections in humans in Gabon.","volume":"10","author":"D\u00e9licat-Loembet","year":"2015","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2602.181120-202001160947-R20","doi-asserted-by":"publisher","first-page":"e1329","DOI":"10.1371\/journal.pntd.0001329","article-title":"Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon.","volume":"5","author":"Akue","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.meegid.2014.04.003","article-title":"Prevalence of the sickle cell trait in Gabon: a nationwide study.","volume":"25","author":"D\u00e9licat-Loembet","year":"2014","journal-title":"Infect Genet Evol"},{"key":"key-10.3201\/eid2602.181120-202001160947-R22","unstructured":"Demographic and Health Surveys Program. Survey summary: Gabon: standard DHS 2012 [cited 2019 Dec 5]. http:\/\/www.measuredhs.com\/what-we-do\/survey\/survey-display-402.cfm"},{"key":"key-10.3201\/eid2602.181120-202001160947-R23","unstructured":"R Core Team. R: a language and environment for statistical computing [cited 2019 Aug 14]. https:\/\/www.r-project.org"},{"key":"key-10.3201\/eid2602.181120-202001160947-R24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.antiviral.2018.10.025","article-title":"Novel amodiaquine derivatives potently inhibit Ebola virus infection.","volume":"160","author":"Sakurai","year":"2018","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2602.181120-202001160947-R25","doi-asserted-by":"publisher","first-page":"e60579","DOI":"10.1371\/journal.pone.0060579","article-title":"A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.","volume":"8","author":"Madrid","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2602.181120-202001160947-R26","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.1038\/srep13476","article-title":"Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting.","volume":"5","author":"Zilbermintz","year":"2015","journal-title":"Sci Rep"},{"key":"key-10.3201\/eid2602.181120-202001160947-R27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S1473-3099(15)70152-0","article-title":"Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study.","volume":"15","author":"Clark","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S1473-3099(16)30516-3","article-title":"Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study.","volume":"17","author":"Etard","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/cid\/cix704","article-title":"Relationship between viremia and specific organ damage in Ebola patients: a cohort study.","volume":"66","author":"Lanini","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R30","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1086\/520444","article-title":"Skeletal muscle involvement in falciparum malaria: biochemical and ultrastructural study.","volume":"29","author":"Davis","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R31","unstructured":"World Health Organization. Malaria control campaign launched in Democratic Republic of the Congo to save lives and aid Ebola response [cited 2019 May 3]. https:\/\/www.afro.who.int\/news\/malaria-control-campaign-launched-democratic-republic-congo-save-lives-and-aid-ebola-response"},{"key":"key-10.3201\/eid2602.181120-202001160947-R32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3201\/eid1507.090402","article-title":"Immunoglobulin G in Ebola outbreak survivors, Gabon.","volume":"15","author":"Wauquier","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R33","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1086\/514309","article-title":"Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995.","volume":"179","author":"Busico","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1286-4579(00)00287-2","article-title":"Ebola and Marburg virus antibody prevalence in selected populations of the Central African Republic.","volume":"2","author":"Gonzalez","year":"2000","journal-title":"Microbes Infect"},{"key":"key-10.3201\/eid2602.181120-202001160947-R35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0923-2516(89)80112-8","article-title":"Antibody prevalence against haemorrhagic fever viruses in randomized representative Central African populations.","volume":"140","author":"Gonzalez","year":"1989","journal-title":"Res Virol"},{"key":"key-10.3201\/eid2602.181120-202001160947-R36","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3201\/eid2505.180115","article-title":"Serologic prevalence of Ebola virus in equatorial Africa.","volume":"25","author":"Steffen","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3201\/eid1103.040981","article-title":"Ebola virus antibody prevalence in dogs and human risk.","volume":"11","author":"Allela","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R38","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1172\/JCI83111","article-title":"Blood kinetics of Ebola virus in survivors and nonsurvivors.","volume":"125","author":"Lanini","year":"2015","journal-title":"J Clin Invest"},{"key":"key-10.3201\/eid2602.181120-202001160947-R39","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1172\/JCI83162","article-title":"Ebola viral load at diagnosis associates with patient outcome and outbreak evolution.","volume":"125","author":"de La Vega","year":"2015","journal-title":"J Clin Invest"},{"key":"key-10.3201\/eid2602.181120-202001160947-R40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1473-3099(17)30111-1","article-title":"Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus.","volume":"17","author":"Glynn","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R41","doi-asserted-by":"publisher","first-page":"E549","DOI":"10.3390\/v10100549","article-title":"Ebola virus maintenance: if not (only) bats, what else?","volume":"10","author":"Caron","year":"2018","journal-title":"Viruses"},{"key":"key-10.3201\/eid2602.181120-202001160947-R42","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3201\/eid2412.180740","article-title":"Survey of Ebola viruses in frugivorous and insectivorous bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015\u20132017.","volume":"24","author":"De Nys","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R43","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/514318","article-title":"Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epid\u00e9mies \u00e0 Kikwit.","volume":"179","author":"Rowe","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R44","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/S0140-6736(00)02405-3","article-title":"Human asymptomatic Ebola infection and strong inflammatory response.","volume":"355","author":"Leroy","year":"2000","journal-title":"Lancet"},{"key":"key-10.3201\/eid2602.181120-202001160947-R45","doi-asserted-by":"publisher","first-page":"e1175","DOI":"10.1371\/journal.pntd.0001175","article-title":"Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus.","volume":"5","author":"Macneil","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2602.181120-202001160947-R46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0169-4758(95)80167-7","article-title":"Host age as a determinant of naturally acquired immunity to Plasmodium falciparum.","volume":"11","author":"Baird","year":"1995","journal-title":"Parasitol Today"},{"key":"key-10.3201\/eid2602.181120-202001160947-R47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ijpara.2014.03.001","article-title":"The reliability of observational approaches for detecting interspecific parasite interactions: comparison with experimental results.","volume":"44","author":"Fenton","year":"2014","journal-title":"Int J Parasitol"},{"key":"key-10.3201\/eid2602.181120-202001160947-R48","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!).","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"key-10.3201\/eid2602.181120-202001160947-R49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.apjtm.2016.12.008","article-title":"An update on the 2014 Ebola outbreak in western Africa.","volume":"10","author":"Shiwani","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"key-10.3201\/eid2602.181120-202001160947-R50","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0140-6736(14)61839-0","article-title":"Ebola control: effect of asymptomatic infection and acquired immunity.","volume":"384","author":"Bellan","year":"2014","journal-title":"Lancet"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/26\/2\/18-1120_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:32:16Z","timestamp":1732987936000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/26\/2\/18-1120_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2602.181120","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}